IRC
ANIX icon

Investors Research Corp’s Anixa Biosciences ANIX Stock Holding History

Investors Research Corp’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed – – 1081
2022
Q1 		$0 Hold
8
– – ﹤0.01% 1022
2021
Q4 		$0 Hold
8
– – ﹤0.01% 983
2021
Q3 		$0 Hold
8
– – ﹤0.01% 992
2021
Q2 		$0 Hold
8
– – ﹤0.01% 975
2021
Q1 		$0 Hold
8
– – ﹤0.01% 976
2020
Q4 		$0 Hold
8
– – ﹤0.01% 1070
2020
Q3 		$0 Hold
8
– – ﹤0.01% 1087
2020
Q2 		$0 Hold
8
– – ﹤0.01% 1083
2020
Q1 		$0 Hold
8
– – ﹤0.01% 1114
2019
Q4 		$0 Hold
8
– – ﹤0.01% 1110
2019
Q3 		$0 Hold
8
– – ﹤0.01% 1114
2019
Q2 		$0 Hold
8
– – ﹤0.01% 1062
2019
Q1 		$0 Buy
+8
New +$38 ﹤0.01% 1031

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investors Research Corp's ANIX Position: Q2 2022 in Review

Investors Research Corp sold out of Anixa Biosciences (ANIX) in Q2 2022, closing a stake of 8 shares.

Investors Research Corp first reported a position in ANIX in Q1 2019 and held it in 13 quarters. The position peaked at $0 in Q1 2022. 45 funds tracked by Wall St. Rank hold ANIX as of Q2 2022.

  • Investors Research Corp reported no remaining Anixa Biosciences position as of Q2 2022 after selling out during the quarter.
  • Investors Research Corp sold 8 Anixa Biosciences shares in Q2 2022.
  • Investors Research Corp first reported a position in Anixa Biosciences in Q1 2019 and held it in 13 quarters.
  • Investors Research Corp's Anixa Biosciences position peaked at $0 in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2022.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.